✉news HealthMedicine first seen 2 d ago, last 2 d ago, peak #8

Retinal AI Could Reshape Screening of Pregnant Patients in Trials

Original: The Eye as a Biomarker: Why Retinal AI Could Reshape How Trials Screen and Stratify Pregnant Patients

A new analysis argues that AI analysis of retinal images could serve as a biomarker to screen and stratify pregnant patients in clinical trials. The piece suggests eye-based data may help identify risk profiles in pregnancy research, where trial enrollment has long been limited by safety concerns. The claim is drawing attention in the clinical research community, though it remains a forward-looking proposal rather than an established practice.

Why now: Growing interest in AI-derived biomarkers and the long-standing gap in including pregnant patients in clinical trials

retinal AIclinical trialspregnant patients

Open on news →

Evidence

• The Eye as a Biomarker: Why Retinal AI Could Reshape How Trials Screen and Stratify Pregnant Patients · The Clinical Trial Vanguard

API: https://socialmediatrends-api.osmike.com/v1/trends/1459003